4Life News

SANDY, UT (October 1, 2004) - In an unprecedented announcement in the history of network marketing, 4Life announced today that 4Life Transfer Factor products as immune modulators have been approved for use in hospitals and clinics in the Russian Federation. The results of ten separate clinical trials and two experimental studies on 4Life Transfer Factor products were combined in a Methodological Document that was approved by the Ministry of Health, which now allows doctors to recommend 4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their patients.

Commenting on this remarkable achievement, David Lisonbee, CEO of 4Life stated, “To my knowledge, this is the first time in the history of this industry that a network marketing company or any other dietary supplement company has had one of its dietary supplements approved for use in hospitals in Russia. The Russian Ministry of Health is the equivalent of the Food and Drug Administration in the United States. Doctors and scientists from Russia have been working jointly with scientists from 4Life for several years to arrive at this accomplishment. This approval establishes a new roll of dietary supplements in the Russian health care system.

In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian Academy of Medical Sciences stated, “The 4Life sample [Transfer Factor Advanced Formula] activated NK (natural killer) cell activity more than the Interleukin-2 (IL2) drug we used as the standard.” This discovery has attracted the attention of The International Scientific and Technical Center (ISTC) of Russia.

The ISTC of Russia is a member of a joint international project with other health agencies of Japan, Europe and the US. The objective of the international project is to combine efforts in finding improved immunotherapies. Following the discoveries from the NK cell testing, the scientists of 4Life have been invited to join the project. 4Life Transfer Factor as an immune modulator will be further researched in this international forum. The cost of the studies will be paid by the ISTC.

Speaking of this benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life, and Dr. Emma Oganova, 4Life/Eurasia President, jointly expressed that because of the acceptance by such a reputable organization and doctors from Russia and other major countries, 4Life Transfer Factor will gain wider acceptance in the professional and private sectors as a superior immune system enhancing product. The worldwide ramifications to this acceptance are just beginning.

4Life Research is the World’s foremost leader in the development, production and distribution of natural immune support products and was recently recognized by Inc. magazine as the fifteenth fastest growing privately-held company in America.

Salt Lake City, Utah (January 8, 2013) 4Life executives are pleased to announce that 4Life Transfer Factor® products are listed in the 2013 Physician’s Desk Reference (PDR).

“We are thrilled to be part of this prestigious and valuable publication. This is the ninth year that 4Life products have been listed,” stated Director of Product Development Chad Renshaw. “The PDR is among the most substantiated resources in the medical community and is distributed to 500,000 health professionals across the United States. Having 4Life products included provides distributors with unrivaled credibility when presenting our products to customers.”

The 2013 edition of the PDR provides in-depth product information about 4Life Transfer Factor® and 4Life® Transfer Factor Plus® Tri-Factor® Formulas. In addition, the publication offers a technical description of the product line and synopses on several scientific studies.

With nine worldwide patents and dozens more pending, an in-house Research and Development team, the scientific input of the Health Sciences Advisory Board, and the industry’s only immunological testing lab, 4Life’s commitment to Transfer Factor science is well established.

Director of Health Information Systems Brent Vaughan: “This professional listing is an invaluable asset for 4Life distributors. The publication strengthens the field’s position as exclusive leaders in the distribution of 4Life Transfer Factor products.”

4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.
 

Salt Lake City, Utah (January 13, 2011) 4Life® President Steve Tew recently announced that December 2010 was the company’s best sales month in company history. Sales for the month were up 19% from the previous year with annual 2010 worldwide sales up over 20%.

Steve Tew: “4Life’s global growth throughout 2010 has been phenomenal. Our worldwide markets continue to post record sales as a result of the strong dedication of our distributors, who each recognize the value of 4Life Transfer Factor® and the business opportunity for success.”

Since the company’s launch in 1998, 4Life has established itself as a world leader in direct sales. In 2003, Inc. 500 recognized 4Life as the 15th fastest growing privately-held company in the United States. In 2010 and 2011, Direct Selling News named 4Life among the top 100 Global Direct Selling Companies.

Five Top-Performing Countries & Regions                                                                 

David Lisonbee, 4Life Founder and CEO from Milan, Italy: “4Life distributors have made 2010 the company’s best year to date. Our corporate team is committed to providing our distributors with the support they need to continue this success. We look forward to ongoing global growth in 2011 and beyond.”

4Life has offices on five continents to service a global network of independent distributors through science, success, and service.

Salt Lake City, Utah (January 3, 2011) 4Life Research™ announced today that the United States Patent & Trademark Office (USPTO) has awarded the company a composition patent that protects the 4Life Transfer Factor® Cardio formula until 2025. This is the company's sixth worldwide patent. 4Life has numerous international patents and dozens of patent applications pending.

4Life’s progressive science and pursuit of patent protection strengthens the business opportunity for 4Life distributors with the exclusive right to market 4Life Transfer Factor® products. 4Life President Steve Tew: “We invest a great deal of resources into patent protection on behalf of our distributors because we know that the opportunity they share must accompany the kind of exclusivity, credibility, and longevity that patents exist to provide.”

4Life's commitment to patents includes an emphasis on research and development to generate formulas, compositions, and processes that are patentable. While 4Life's legal team concentrates on patent acquisition, the International Product Registration department focuses on registrations around the world to support distributor growth now and in the future. In 2010, 4Life completed 101 product registrations in 30 countries.

4Life Founder and CEO David Lisonbee: "Patent protection is just one way that we work to empower 4Life distributors with exclusivity and credibility in the marketplace. 4Life patents provide our distributors with security for decades to come.

4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.

Mark Todd & his horse, Gandalf

Salt Lake City, Utah (June 19, 2008) 4Life Research™ announced today that Mark Todd, famed New Zealand equestrian, will publicly endorse 4Life Products.

Todd was voted Rider of the 20th century by the International Equestrian Federation. He is a four-time Olympic medalist, including two gold medals. He primarily competes in eventing, which includes dressage, cross-country, and show jumping. In 1984 and 1988, he was the first rider to win successive individual three-day-event Olympic gold medals in 60 years. He won the prestigious Badminton Horse Trials on three occasions and the Burghley three-day trials five times.

He retired from eventing following the 2000 Sydney Olympics, but decided to make a return for the 2008 Beijing Olympics. In May 2008 he qualified for the 2008 Olympics at the three-day event in Samur, France.

“I am 52 years old and competing in my fifth Olympics,” remarked Todd. “I use 4Life Transfer Factor Plus® to help keep me at the top of my game. It provides the well-being and healthy energy support I need to continue at top-level competition.”

“I’m very excited to have Mark Todd endorse 4Life Products,” commented Vice President, International Jason Norton. “As an accomplished equestrian in New Zealand, his endorsement speaks volumes to distributors and new recruits about the quality of our products. This is exciting news for
4Life markets around the world.”

“I’m thrilled about Todd’s endorsement agreement,” remarked Managing Director of 4Life Australia and New Zealand Ben Riley. “He understands the importance that nutrition and supplementation play in maintaining wellness, and uses 4Life Products to help him perform his best.”

4Life, the leader in the development, production, and distribution of Transfer Factor support products, continues to post growth in more than 40 countries around the world.

4Life Transfer Factor® Products Approved for Use by Olympic Athletes

 

Salt Lake City, Utah (December 4, 2007) As first reported by 4Life Chief Scientific Officer Calvin McCausland, Ph.D., in Direct Selling News, 4Life received documentation from the Federal Anti-Doping Center in Moscow, Russia, that admits 4Life Transfer Factor for use by Olympians in practice, training, and competition. Approval was obtained after volunteers consumed 4Life Transfer Factor products and their bodily fluids were analyzed in accordance with doping control procedures that employ modern methods of gas chromatography and mass-spectrometry in compliance with the World Anti-Doping Agency in Montreal, Canada. “We are very pleased by this approval,” commented President of Eurasia Emma Oganova, M.D., Ph.D. “4Life Transfer Factor continues to define the cutting-edge of immune system science.” 4Life Founder and Chief Executive Officer David Lisonbee launched 4Life Research in 1998 with a commitment to the highest scientific standards. Ongoing research and development of Transfer Factor technology has fueled 4Life’s constant growth and maximized every distributor’s ability to grow a successful independent business. “Arguably, this kind of marketplace positioning and high level product messaging simply isn’t possible without the involvement of a professional research and development team,” added McCausland. “I am pleased with our continued evolution in the supplement industry,” stated Executive Vice President Bruce Redd. “The quality work of our Research and Development department is certain to keep 4Life on the leading edge of science and success for years to come.” 4Life, the leader in the development, production, and distribution of Transfer Factor support products, continues to post growth in more than 40 countries around the world.